Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Simulect (basiliximab)
i
Other names:
CHI 621, Chimeric RFT5, chRFT5, SDZ CHI 621, CHI-621, CHI621
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Novartis
Drug class:
CD25 inhibitor
Related drugs:
‹
ALD2510 (0)
ANV419 (0)
AU-007 (0)
INV322 (0)
daclizumab (0)
RG6292 (0)
ALD2510 (0)
ANV419 (0)
AU-007 (0)
INV322 (0)
daclizumab (0)
RG6292 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login